Home » Transgenomic, NCI Collaborating on Mitochondrial Genome Characterization in Cancer Cell Lines

Transgenomic, NCI Collaborating on Mitochondrial Genome Characterization in Cancer Cell Lines

Apr 30, 2008
NEW YORK (GenomeWeb News) – The National Cancer Institute has approved a proposal by the genetic analysis and services company Transgenomic to do mutational analysis and sequencing on mitochondrial genes in the NCI 60 panel of cancer cell lines, the company announced today.
 
The collaboration between NCI and Omaha, Neb.-based Transgenomic is expected to be the first comprehensive evaluation of the mitochondrial genome in this cell panel, which has been used to test compounds in NCI’s pharmacological database.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.